Intco Medical Technology Co., Ltd.

SZSE:300677 Stock Report

Market Cap: CN¥17.5b

Intco Medical Technology Future Growth

Future criteria checks 5/6

Intco Medical Technology is forecast to grow earnings and revenue by 46.1% and 21.8% per annum respectively.

Key information

46.1%

Earnings growth rate

n/a

EPS growth rate

Medical Equipment earnings growth23.9%
Revenue growth rate21.8%
Future return on equityn/a
Analyst coverage

Low

Last updated01 Mar 2024

Recent future growth updates

Recent updates

Intco Medical Technology (SZSE:300677) Seems To Use Debt Quite Sensibly

Aug 19
Intco Medical Technology (SZSE:300677) Seems To Use Debt Quite Sensibly

Intco Medical Technology Co., Ltd. (SZSE:300677) Looks Inexpensive But Perhaps Not Attractive Enough

Jul 15
Intco Medical Technology Co., Ltd. (SZSE:300677) Looks Inexpensive But Perhaps Not Attractive Enough

Capital Allocation Trends At Intco Medical Technology (SZSE:300677) Aren't Ideal

May 21
Capital Allocation Trends At Intco Medical Technology (SZSE:300677) Aren't Ideal

Intco Medical Technology (SZSE:300677) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

May 02
Intco Medical Technology (SZSE:300677) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Intco Medical Technology Co., Ltd.'s (SZSE:300677) Business Is Trailing The Market But Its Shares Aren't

Mar 28
Intco Medical Technology Co., Ltd.'s (SZSE:300677) Business Is Trailing The Market But Its Shares Aren't

Earnings and Revenue Growth Forecasts

SZSE:300677 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202511,1861,333N/A1,5591
12/31/20248,962864N/A1,1941
6/30/20248,136677-763723N/A
3/31/20247,549774-532839N/A
12/31/20236,919383-936502N/A
9/30/20236,444321-629-3N/A
6/30/20236,168520-504352N/A
3/31/20235,899393-865474N/A
1/1/20236,614629-6501,065N/A
9/30/20227,8061,126-7181,688N/A
6/30/20229,3061,954-4062,766N/A
3/31/202211,7933,7781,7436,021N/A
1/1/202216,2407,4303,2368,680N/A
9/30/202118,5389,5775,40711,705N/A
6/30/202120,06110,9656,93012,690N/A
3/31/202119,79810,6146,81011,390N/A
12/31/202013,8377,0075,6908,590N/A
9/30/20209,5034,4253,6985,388N/A
6/30/20205,5482,0291,6962,781N/A
3/31/20202,362274-46543N/A
12/31/20192,083178-207330N/A
9/30/20192,042176-212204N/A
6/30/20192,003181-73251N/A
3/31/20191,963191-132200N/A
12/31/20181,893179-123186N/A
9/30/20181,818162-155193N/A
6/30/20181,764153-123213N/A
3/31/20181,776147N/A282N/A
12/31/20171,750145N/A248N/A
9/30/20171,639134N/A155N/A
6/30/20171,50197N/A96N/A
3/31/20171,31484N/A67N/A
12/31/20161,18386N/A81N/A
12/31/201599864N/A76N/A
12/31/201488532N/A77N/A
12/31/201371311N/A75N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 300677's forecast earnings growth (46.1% per year) is above the savings rate (2.9%).

Earnings vs Market: 300677's earnings (46.1% per year) are forecast to grow faster than the CN market (16.8% per year).

High Growth Earnings: 300677's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 300677's revenue (21.8% per year) is forecast to grow faster than the CN market (10.4% per year).

High Growth Revenue: 300677's revenue (21.8% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if 300677's Return on Equity is forecast to be high in 3 years time


Discover growth companies